Pharmacological Effects of Serum Containing Chinese Medicine Bushen Huayu Jiedu Compound Recipe (补肾化瘀解毒复方) in Lung Cancer Drug-resistance Cells

被引:17
作者
曹勇
夏清华
孟华
钟安朴
机构
[1] DepartmentofTraditionalChineseMedicine,JinanUniversityMedicalSchool,Guangzhou()
关键词
D O I
暂无
中图分类号
R273 [中医肿瘤科];
学科分类号
100502 [中医临床基础];
摘要
<正>Objective:To explore the pharmacologic effects of Chinese medicine Bushen Huayu Jiedu Compound Recipe(补肾化瘀解毒复方,BSHYJDR)in drug-resistance cells of lung cancer. Methods:Human lung adenocarcinoma A549/DDP cell strain was selected,serum pharmacology and flow cytometer(FCM)method were adopted,S180 tumor-bearing mice and normal mice were given,through gastrogavage,different doses of a decocted concentration of BSHYJDR.Serum from the abdominal aorta was taken to observe the effect of drug-serum on cisplatin(DDP)concentration, free Ca2+concentration and the expression of lung drug-resistance protein LRP-56 in A549/DDP cells.Results:Compared with the drug-resistance group,the intracellular DDP concentration in the group taking a high dose and the normal group of Chinese medicine showed significant difference (P<0.05),while no significant difference was found in the low-dose group(P>0.05).Compared with the drug-resistance group,the Ca2+concentration in cells and the expression of LRP in lung cancer drug-resistance cells A549/DDP of the high-dose group,the low-dose group and the normal group of Chinese medicine were significantly different(all P<0.01),the LRP expression of the normal group was obviously higher than that of the drug-resistance group(P<0.05).Conclusion:It was indicated that serum containing Chinese medicine BSHYJDR in the tumor-bearing mice and the normal mice had certainly different,tumor-bearing mice serum containing could improve drug concentration in lung cancer drug-resistance cells,prevent the inflow and release of Ca2+,and inhibit the expression of the drug-resistance gene in the lung cancer drug-resistance cells,which might be the mechanism of BSHYJDR in enhancing the efficacy in reversing and inhibiting tumor.
引用
收藏
页码:46 / 50
页数:5
相关论文
共 2 条
[1]
Biology of the multidrug resistance-associated protein, MRP [J].
Lee, DW ;
Deeley, RG ;
Cole, SPC .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (06) :945-957
[2]
EFFECT OF KN-62, CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE-II INHIBITOR, ON ADRIAMYCIN RESISTANCE OF HUMAN OVARIAN-CANCER CELLS [J].
OBATA, NH ;
OKAZAKI, K ;
MAEDA, O ;
KIKKAWA, F ;
TOMODA, Y ;
HIDAKA, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 215 (02) :566-571